Patients with hepatitis B and the TT genotype may have an increased response to treatment with peginterferon-alpha 2a and/or 2b as compared to patients with the CC or CT genotypes. However, one study found this association in the opposite direction, while another failed to find an association. Other genetic and clinical factors may also affect a patient's response to treatment peginterferon-alpha 2a and/or 2b